LYPD2 (LY6/PLAUR domain containing 2) is a member of the lymphocyte antigen-6 (LY6) gene family located on chromosome 8.3, a frequently amplified locus in human cancer 1. The protein contains a characteristic LU domain and localizes to the plasma membrane and extracellular region, with protein binding capacity 1. LYPD2 shows altered expression in multiple cancers, with overexpression identified in gallbladder cancer transcriptome analysis 2 and significant association with gastric cancer risk through genome-wide association studies 3. In gastric cancer, LYPD2 participates in pathways related to glycosylphosphatidylinositol (GPI)-anchored protein synthesis and membrane components 3. Beyond cancer, LYPD2 expression is regulated in epitranscriptomic alterations associated with clopidogrel resistance in coronary artery disease patients 4. LYPD2 transcription is also modulated by human papillomavirus E8^E2 protein phosphorylation, suggesting a role in host-pathogen interactions 5. While the precise molecular mechanisms remain incompletely defined, LYPD2 represents a biomarker for poor cancer prognosis and may facilitate cancer progression and immune escape 1.